Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506

被引:29
作者
Fukunaga, J
Yamaai, T
Yamachika, E
Ishiwari, Y
Tsujigiwa, H
Sawaki, K
Lee, YJ
Ueno, T
Kirino, S
Mizukawa, N
Takagi, S
Nagai, N
Sugahara, T
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008525, Japan
[2] Okayama Univ, Grad Sch Med & Dent, Dept Oral Funct & Anat, Okayama 7008525, Japan
[3] Okayama Univ, Grad Sch Med & Dent, Dept Oral Pathol & Med, Okayama 7008525, Japan
关键词
ODF; OCIF; osteoporosis; immunosuppressant; FK506; osteoblast;
D O I
10.1016/j.bone.2003.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunosuppressant drugs are currently required by transplant recipients for the remainder of their lives, despite the many adverse effects associated with these therapies. Acute osteoporosis is one such effect, and a reproducible osteoporosis model has been established through the administration of the immunosuppressant drug FK506 in rats. The cause of this osteoporosis has been shown to be abnormal osteoclast proliferation.. altering the process of bone remodeling. However, the reasons why FK506 induces osteoclast proliferation and whether this process is mediated by cytokine changes or an increase in bone resorption factors have been unclear, An investigation was therefore conducted focusing on the recent discoveries of osteoclast differentiation factor (ODF) and osteoclastogenesis inhibitory factor (OCIF). These factors led to elucidation of the osteoclast differentiation-maturation mechanism. An osteoporosis model was produced in rats utilizing intramuscular FK506 injection (1 mg/kg) for 28 consecutive days. Trabecular bone resorption was observed inferior to enchondral ossification in the FK506 group, and tartrate resistant acid phosphatase (TRAP) staining revealed a clear increase in osteoclasts at the site of enchondral ossification, relative to the control group. Real-time PCR and in situ hybridization (ISH) demonstrated minimal differences in OCIF expression between control and the treatment groups. However, Real-time PCR revealed clearly increased ODF expression in the treatment group. ODF expression was also shown to be increased in the treatment group using ISH. This was histologically consistent with a region of osteoclast proliferation inferior to enchondral ossification. The results of this study support the hypothesis that FK506-mediated osteoporosis occurs by action of the drug on osteoclasts, promoting expression of ODF messenger ribonucleic acid (mRNA) and thus prompting osteoclast differentiation and maturation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:425 / 431
页数:7
相关论文
共 29 条
[1]   THE STRUCTURE OF THE B-SUBUNIT OF CALCINEURIN [J].
AITKEN, A ;
KLEE, CB ;
COHEN, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 139 (03) :663-671
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia [J].
Buchinsky, FJ ;
Ma, YF ;
Mann, GN ;
Rucinski, B ;
Bryer, HP ;
Romero, DF ;
Jee, WSS ;
Epstein, S .
ENDOCRINOLOGY, 1996, 137 (06) :2278-2285
[4]   THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE-A, CYCLOSPORINE-G, AND FK506 ON BONE-MINERAL METABOLISM IN-VIVO [J].
CVETKOVIC, M ;
MANN, GN ;
ROMERO, DF ;
LIANG, XG ;
MA, YF ;
JEE, WSS ;
EPSTEIN, S .
TRANSPLANTATION, 1994, 57 (08) :1231-1237
[5]  
FUKUNAGA J, 2000, JPN SOC BONE MINER R, V18, P269
[6]  
Gravallese EM, 1998, AM J PATHOL, V152, P943
[7]   CLONING OF HUMAN CALCINEURIN-A - EVIDENCE FOR 2 ISOZYMES AND IDENTIFICATION OF A POLYPROLINE STRUCTURAL DOMAIN [J].
GUERINI, D ;
KLEE, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9183-9187
[8]  
Jimi E, 1999, J IMMUNOL, V163, P434
[9]  
Klee C B, 1980, Ann N Y Acad Sci, V356, P43, DOI 10.1111/j.1749-6632.1980.tb29598.x
[10]   OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis [J].
Kong, YY ;
Yoshida, H ;
Sarosi, I ;
Tan, HL ;
Timms, E ;
Capparelli, C ;
Morony, S ;
Oliveira-dos-Santos, AJ ;
Van, G ;
Itie, A ;
Khoo, W ;
Wakeham, A ;
Dunstan, CR ;
Lacey, DL ;
Mak, TW ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 397 (6717) :315-323